Home
About
Contact
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development

Precision Lifesciences Group

Home
About
Contact
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development
louis-reed-747388-unsplash.jpg

Publications

  • Technology
  • Cancer Immunotherapy
  • Stem-to-T-Cell Platform
  • Dendritic Cell-Based Immunotherapeutics
  • Dendritic Cell-Based Manufacturing
  • Publications
  • Resources
  • A Randomized Double Blind Placebo-Controlled Phase 2 Trial of Dendritic Cell (DC) Vaccine ICT-107 Following Standard Treatment in Newly Diagnosed Patients with GBM
    NEURO-ONCOLOGY, Vol. 16, Issue Suppl. 5, v22, 2014

  • A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Dendritic cell (DC) Vaccination with ICT-107 in Newly Diagnosed Glioblastoma (GBM) Patients.
    2014 ASCO Annual Meeting, Abstract 2005, Citation: J Clin Oncol 32:5s, 2014

  • Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
    CLINICAL AND DEVELOPMENTAL IMMUNOLOGY, Vol. 2012, Article ID 764213

  • Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
    MEDIATORS OF INFLAMMATION, Vol. 2012, Article ID 690643

  • ImmunoCellular Therapeutics ICT-107 Phase 1 results:
    Phase I Trial of a Multi-Epitope-Pulsed Dendritic Cell Vaccine for Patients with Newly Diagnosed Glioblastoma
    CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol. 62, Issue 1, pages 125-135, January 2013

  • The Therapeutic Promise of the Cancer Stem Cell Concept
    THE JOURNAL OF CLINICAL INVESTIGATION, Vol.120, No. 1, pages 41-50, January 2010

  • Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
    STEM CELLS EXPRESS Vol. 27, Issue 8, pages April 23, 2009

  • Isolation of Tumour Stem-like Cells from Benign Tumours
    BRITISH JOURNAL OF CANCER Vol. 101, No. 2, pages 303 – 311, 2009

  • Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
    CANCER RESEARCH, Vol. 68, No.14, pages 5955-5964, July 15, 2008

  • Cancer Vaccines: A Novel Strategy to Sensitize Malignant Glioma to Chemotherapy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, Vol. 7 No. 10, pages 1235–1237, 2007

  • Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma
    CANCER RESEARCH, Vol. 64, pages 4973– 4979, July 15, 2004

  • HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells
    THE NEW YORK TIMES, by Nicholas Wade, Page A1, August 13, 2009

  • Vaccination of Malignant Glioma Patients with Peptide-pulsed Dendritic Cells,
    CANCER RESEARCH, Vol. 61, pages 842– 847, February 1, 2001

Subscribe

Sign up with your email address to receive news and updates.

Thank you!
Back to Top

Terms of Use | Privacy Policy